Table 2 Baseline participant characteristics

Male/female (n)

8/8

13/11

Age (year-old)

68.4 ± 12.8

66.7 ± 13.4

Height (cm)

154.3 ± 8.8

154.9 ± 9.6

Duration of diabetes (years)

9.6 ± 6.5

6.6 ± 3.9

Medication

Anti-diabetic drugs (%, n)

68.8% (11)

79.2% (19)

Insulin (n)

1

8

Sulfonylureas (n)

1

4

Meglitinide (n)

2

3

Biguanide (n)

7

11

α-glucosidase inhibitors (n)

2

1

Thiazolidinedione (n)

0

0

DPP-4 inhibitors (n)

2

1

Anti-hypertensive drugs (%, n)

56.3% (9)

62.5% (15)

Lipid lowering drugs (%, n)

12.5% (2)

8.3% (2)